iGlarLixi : A titrateable fixed‐ratio combination of basal insulin + GLP‐1 receptor agonist—An effective type 2 diabetes treatment option in China

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	Miao Yu
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Diabetes, Obesity and Metabolism
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet